Johnson & Johnson (JNJ) Gross Margin Growth (5y) (2014 - 2026)

Johnson & Johnson (JNJ) Gross Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -205.00
Dec 28, 2025 233.00
Sep 28, 2025 263.00
Jun 29, 2025 375.00
Mar 30, 2025 53.00
Dec 29, 2024 273.00
Sep 29, 2024 214.00
Jun 30, 2024 315.00
Mar 31, 2024 259.00
Dec 31, 2023 236.00
Oct 1, 2023 144.00
Jul 2, 2023 323.00
Apr 2, 2023 105.00
Jan 1, 2023 543.00
Oct 2, 2022 438.00
Jul 3, 2022 -24.00
Apr 3, 2022 11.00
Oct 3, 2021 -28.00
Jul 4, 2021 -367.00
Apr 4, 2021 -116.00